Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,685-3,696 of 10,612

Drug study icon

CompletedNCT02504151

Cannabidiol Treatment in people with Early Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT00588731

Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT04192370

Cannabidiol Use to Reduce Cravings in Individuals With Addiction on Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Addiction

Behavioral study icon

CompletedNCT02069366

Cannabinoid Control of Fear Extinction Neural Circuits in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 21 Years to 45 Years

Countries: United States
Sponsor: Wayne State University
Condition: PTSD

Behavioral study icon

CompletedNCT02911324

Cannabinoid Medication for Adults With OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

Drug study icon

CompletedNCT06430580

Cannabinoids and Biological Reactivity to Stress

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Florida State University
Condition: Addiction

Behavioral study icon

CompletedNCT01853020

Cannabinoids and Cerebellar-Motor Functioning

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 21 Years to 35 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00708994

Cannabinoids, Neural Synchrony, and Information Processing

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT00946348

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT04228965

Cannabis and Tobacco Co-use Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

CompletedNCT04230460

Cannabis Impairment Detection Application (CIDA)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Advanced Brain Monitoring, Inc.
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.